Sorrento Therapeutics Inc Quick Ratio (SRNEQ) starting from the second quarter 2023 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Sorrento Therapeutics Inc   (SRNEQ)

Sorrento Therapeutics Inc 's Quick Ratio

SRNEQ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2023, Quick Ratio fell to 0.3 below Sorrento Therapeutics Inc average.

Within Biotechnology & Pharmaceuticals industry 167 other companies have achieved higher Quick Ratio than Sorrento Therapeutics Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 3349 to 3382.

Explain Quick Ratio?
How much Cash & cash equivalents SRNEQ´s has?
What are SRNEQ´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SRNEQ Quick Ratio (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2
Y / Y Current Liabilities Change 82.32 % -18.9 % 142.38 % 15.3 % -19.47 %
Y / Y Cash & cash equivalent Change -39.65 % -81.41 % -60.61 % -27.55 % 19.61 %
Quick Ratio MRQ 0.3 0.3 0.16 0.58 0.92
SRNEQ's Total Ranking # 3382 # 3349 # 3540 # 2313 # 1860
Seq. Current Liabilities Change 59.96 % -48.2 % 58.3 % 38.99 % -28.84 %
Seq. Cash & cash equivalent Change 60.25 % 0.68 % -57.6 % -11.78 % -50.64 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 168
Healthcare Sector # 979
Overall Market # 3382


Quick Ratio Statistics
High Average Low
8.72 2.43 0.15
(Dec 31 2012)   (Dec 31 2022)




Financial Statements
Sorrento Therapeutics Inc 's Current Liabilities $ 265 Millions Visit SRNEQ's Balance sheet
Sorrento Therapeutics Inc 's Cash & cash equivalent $ 81 Millions Visit SRNEQ's Balance sheet
Source of SRNEQ's Sales Visit SRNEQ's Sales by Geography


Cumulative Sorrento Therapeutics Inc 's Quick Ratio

SRNEQ's Quick Ratio for the trailling 12 Months

SRNEQ Quick Ratio

 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 45.02 % 20.37 % 49.29 % 24.68 % 41.18 %
Y / Y Cash & cash equivalent TTM Growth -56.93 % -47.65 % -10.24 % 14.47 % 44.71 %
Quick Ratio TTM 0.31 0.42 0.66 0.95 1.06
Total Ranking TTM # 4232 # 4060 # 4129 # 4118 # 4089
Seq. Current Liabilities TTM Growth 14.37 % -4.43 % 27.48 % 4.08 % -5.08 %
Seq. Cash & cash equivalent TTM Growth -15.06 % -38.51 % -11.85 % -6.46 % 3.26 %

Quick ratio ranking by company, industry and sector >> Back to SRNEQ Financial Strength Comparisons >> Go to Compare SRNEQ Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q2 2023 to $264.95 millions, cumulative Quick Ratio decreased to 0.31 below the Sorrento Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 180 other companies have achieved higher Quick Ratio than Sorrento Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2023 from 4060 to 4232.

Explain Quick Ratio?
How much Cash & cash equivalents SRNEQ´s has?
What are SRNEQ´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 181
Healthcare Sector # 1118
Within the Market # 4232


trailing twelve months Quick Ratio Statistics
High Average Low
6.56 1.81 0.25
(March 31, 2015)   (Jun 30 2020)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Biotechnology & Pharmaceuticals Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Valneva Se  0.79 $ 141.210  Millions$ 177.927  Millions
Agenus Inc  0.77 $ 157.852  Millions$ 204.068  Millions
Sab Biotherapeutics Inc   0.71 $ 7.774  Millions$ 11.011  Millions
Outlook Therapeutics Inc   0.68 $ 33.709  Millions$ 49.930  Millions
Dbv Technologies S a   0.66 $ 24.111  Millions$ 36.443  Millions
Orchard Therapeutics Plc  0.64 $ 38.274  Millions$ 60.105  Millions
Champions Oncology Inc   0.61 $ 4.869  Millions$ 7.996  Millions
10x Capital Venture Acquisition Corp Iii  0.47 $ 1.964  Millions$ 4.153  Millions
Tevogen Bio Holdings Inc   0.37 $ 0.556  Millions$ 1.521  Millions
Atlantic Coastal Acquisition Corp Ii  0.35 $ 2.228  Millions$ 6.388  Millions
Armata Pharmaceuticals Inc   0.34 $ 12.456  Millions$ 37.034  Millions
Scilex Holding Company  0.33 $ 34.122  Millions$ 103.583  Millions
Novavax inc   0.32 $ 505.912  Millions$ 1,596.255  Millions
Elutia Inc   0.31 $ 9.296  Millions$ 30.041  Millions
Sorrento Therapeutics Inc   0.30 $ 80.635  Millions$ 264.949  Millions
Xtant Medical Holdings Inc   0.24 $ 4.138  Millions$ 16.989  Millions
Eloxx Pharmaceuticals Inc   0.21 $ 4.331  Millions$ 20.759  Millions
Zeo Scientifix Inc   0.20 $ 0.661  Millions$ 3.316  Millions
Kiromic Biopharma Inc   0.14 $ 2.704  Millions$ 18.700  Millions
Cyclo Therapeutics Inc   0.14 $ 0.842  Millions$ 6.078  Millions
Mosaic Immunoengineering Inc   0.10 $ 0.363  Millions$ 3.546  Millions
Brainstorm Cell Therapeutics inc   0.10 $ 0.748  Millions$ 7.691  Millions
Redwoods Acquisition Corp  0.09 $ 0.124  Millions$ 1.352  Millions
Calidi Biotherapeutics Inc   0.08 $ 0.670  Millions$ 8.182  Millions
Immunitybio inc   0.07 $ 45.954  Millions$ 613.478  Millions
Gilead Sciences Inc   0.07 $ 963.000  Millions$ 13,964.000  Millions
Tracon Pharmaceuticals Inc   0.06 $ 1.735  Millions$ 27.073  Millions

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.